Amneal Pharmaceuticals
Amneal Pharmaceuticals (United States) holds 1 active US FDA Type II Drug Master File, has DMF or CEP filings on record for 1 active ingredient, holds 34 active Type IV (excipient) Drug Master Files and is linked to 3 FDA-registered manufacturing sites. 50 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Amneal Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/amneal-pharmaceuticals
Overview
Amneal Pharmaceuticals is a publicly traded company specializing in the development, manufacture, and distribution of generic and specialty pharmaceutical products. With a commitment to providing affordable medication, the company has established a broad portfolio addressing a wide range of therapeutic areas.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Amneal Pharmaceuticals holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Amneal Pharmaceuticals holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- GLATIRAMER ACETATEActive2013-12-12
Excipient Drug Master Files
Amneal Pharmaceuticals holds 34 active (34 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- NATURAL BANANA WONF FLAVOR UD-1190Active2020-07-20
- NATURAL AND ARTIFICIAL MIXED FRUIT ENHANCER FLVP UA-7817Active2020-07-17
- NATURAL AND ARTIFICIAL MIXED FRUIT FLVP FT 1789Active2017-04-07
- NATURAL AND ARTIFICIAL ORANGE FLVP FLAVOR FZ-6607Active2016-12-02
- NATURAL/ARTIFICIAL BERRY FLAVOR FY-6884Active2016-06-10
- NATURAL/ARTIFICIAL ORANGE EXTRACT FLAVOR FZ-4297Active2016-06-10
- ARTIFICIAL TUTTI FRUITTI FLVP FT-5103Active2016-06-10
- NAT. MARASCHINO CHERRY TYPE CONCENTRATE FI FW-9004Active2013-12-18
- ARTIFICIAL JUICY RASPBERRY FLAVOR FW-4870Active2013-07-08
- ARTIFICAL CARAMEL FLAVOR FV-8873Active2013-02-13
- ARTIFICIAL BANANA FLVP FT-8072Active2013-02-13
- NAT/ART CREME DE VANILLA FLVP FT-8073Active2013-02-13
- N/A CHERRY FLAVOR FV-7379Active2012-10-16
- NATURAL ORANGE WONF FLAVOR FU-6556Active2011-10-12
- N/A FRUIT TOPNOTE FLAVOR FU-6558Active2011-10-12
- NATURAL AND ARTIFICIAL CHERRY FLVP FT-9496Active2011-07-26
- NATURAL AND ARTIFICIAL BUBBLEGUM FLAVOR FU-3869Active2011-05-12
- NATURAL AND ARTIFICIAL LEMON LIME FLVP FT-867Active2011-04-27
- ARTIFICIAL GRAPE FLAVOR FT - 2968Active2011-02-16
- NATURAL AND ARTIFICIAL YELLOW PLUM LEMON FLAVOR FT-5399Active2010-12-06
- NATURAL AND ARTIFICIAL ORANGE FLVP FO-9464Active2010-06-09
- NATURAL PEPPERMINT FLAVOR FT-3494Active2010-04-23
- NATURAL CITRUS WONF FLAVOR FT-2811Active2010-04-23
- NATURAL AND ARTIFICIAL STRAWBERRY ANISE FLAVOR FS-5206Active2010-03-26
- ARTIFICIAL TUTTI FRUITTI FLAVOR FS-6943Active2010-01-20
- ARTIFICIAL GRAPE FLAVOR FN-5393Active2008-05-14
- N/A PINEAPPLE FLAVOR FM-4130Active2006-08-16
- ART. STRAWBERRY FLAVOR FO-1022Active2006-07-31
- N/A COUGH SYRUP MASKER FLAVOR FN-6819Active2006-07-31
- N/A FRUIT FLAVOR FN-6714Active2006-04-12
Showing 30 of 34 excipient filings, active first.
Registered manufacturing sites (3)
Physical sites registered with the US FDA and resolved to Amneal Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
50 FDA enforcement records linked to this company.
- recall — Class II2026-10-07
Defective Container; packets were found to be either empty or partially full.
- recall — Class III2026-06-17
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
- recall — Class I2026-04-08
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
- recall — Class II2026-04-08
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
- recall — Class II2025-09-10
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
- recall — Class II2025-09-10
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
- recall — Class II2025-09-10
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
- recall — Class II2025-09-10
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
- recall — Class II2025-09-10
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
- warning_letter2025-08-27
FDA Warning Letter (drug product)
- recall — Class I2025-06-18
Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
- recall — Class I2025-05-14
Presence of Particulate Matter
- recall — Class III2024-08-14
Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.
- recall — Class II2019-12-18
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
- recall — Class II2019-12-18
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
- recall — Class II2019-12-18
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
- recall — Class II2019-12-18
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
- recall — Class II2019-12-18
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
- recall — Class III2019-11-20
Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.
- recall — Class III2019-10-16
Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle
- recall — Class III2019-07-31
Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets
- recall — Class III2019-07-10
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
- recall — Class III2019-07-10
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
- 4832019-05-24
Habits of good sanitation & health
- 4832019-05-24
Failure to meet specifications
- 4832019-02-21
Reports of Analysis (Components)
- 4832019-02-21
Investigations of discrepancies, failures
- 4832019-02-21
Incoming material area
- recall — Class II2018-04-04
Presence of particulate matter
- recall — Class II2017-11-22
Presence of Particulate Matter
- 4832017-10-25
Calibration/Inspection/Checking not done
- 4832017-10-25
Written procedures not established/followed
- 4832017-10-25
Sanitation--buildings not clean, free of infestation
- 4832017-10-25
Procedures not in writing, fully followed
- 4832017-10-25
Cleaning SOP/inspection
- 4832017-05-24
Cleaning SOPs/equipment protection
- 4832017-05-24
Calibration/Inspection/Checking not done
- 4832017-05-24
Control procedures to monitor and validate performance
- recall — Class II2017-05-10
Failed Dissolution Specifications
- 4832013-11-13
Failure to meet specifications
- 4832013-07-03
Written procedures not established/followed
- 4832013-07-03
Establishment of time limitations
- 4832013-07-03
Procedures not in writing, fully followed
- 4832010-05-26
Failure to meet specifications
- 4832010-05-26
Investigations of discrepancies, failures
- 4832008-11-10
Investigations of discrepancies, failures
- 4832008-11-10
Calibration - at intervals, written program, remedial action
- 4832008-11-10
Procedures not in writing, fully followed
- 4832008-11-10
Failing drug products not rejected
- 4832008-11-10
Written procedures not established/followed
Is this Amneal Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.